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Background: Women with fibromyalgia (FM) describe great difficulties in managing work. Reported work ability in
women with FM varies from 34 to 77 percent in studies from different countries. Many factors are suggested to
affect the ability to work in women with FM, including pain, fatigue, impaired physical capacity and activity
limitations. However, it is difficult to define to which extent symptom severity can be compatible with work. The
aim of this study was to investigate which aspects of health differ between working women with FM and
nonworking women with FM.
Methods: A cross-sectional study of 129 women of working age with FM which included clinical assessment,
structured interviews, questionnaires and performance-based tests. The women were categorized as working or
nonworking. Aspects of health are presented according to the International Classification of Functioning, Disability
and Health (ICF).
Results: Working women with FM presented better health than nonworking women with FM in ratings of body
function (FIQ pain p < 0.001, FIQ fatigue p = 0.006, FIQ stiffness p = 0.009, HADS-Depression p = 0.007). Ratings of
overall health status were also significantly better in working women with FM than in nonworking women with FM
(FIQ total, eight-item p = 0.001 and SF-36 PCS p < 0.001). No significant differences were found between working-
and nonworking women in tests of physical capacity. FIQ pain was an independent explanatory factor for work in
stepwise multiple logistic regression analysis (OR 0.95, CI 0.93- 0.98), p < 0.001.
Conclusion: Working women with FM reported better health than nonworking women with FM in terms of pain,
fatigue, stiffness, depression, disease specific health status and physical aspects of quality of life, which represent
body functions and overall health status. However, they were equally impaired in tests of physical capacity.
Moderate pain levels were compatible with work, while severe pain appeared to compromise work. Fatigue was
better tolerated, as women scoring severe levels of fatigue worked.
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The research criteria of fibromyalgia (FM) as defined by
the American College of Rheumatology (ACR) criteria
for FM include a history of widespread pain for at least
three months and pain on manual palpation in 11 of 18
tender points [1]. FM is characterized by persistent wide-
spread pain, increased pain sensitivity and tenderness [1].* Correspondence: annie.palstam@gu.se
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reproduction in any medium, provided the orOther associated symptoms are fatigue, psychological
distress [1,2], activity limitations [3] and impaired phys-
ical capacity [4]. The prevalence of FM ranges from 1 to
3% in the general population, it is more common among
women and increases with age [2,5].
Activity limitations in FM have an impact on work
ability [6]. FM imposes a heavy patient burden in terms
of disability, loss of quality of life and costs, and it
imposes an economic burden on society [7]. The degree
of employment in FM varies geographically, with a range
from 34% to 77% in different studies [8]. The wide rangel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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labour markets of different countries [8]. Working women
with FM have previously been reported to experience less
pain, less fatigue and better functional status than non-
working women with FM [9]. Severe pain and fatigue
combined with a demanding life situation and ageing have
been associated with work disability in FM, as well as self
rated disability and unmarried status [10,11].
Disability benefits in Sweden are approved when a dis-
ease impairs a person’s ability to work by at least 25%.
Approximately 72% of all women in Sweden of working
age (16–64 years) were employed in the year 2005 and
8% received full-time disability benefits1.
Interview studies have indicated that the severity of
symptoms and psychosocial and environmental factors
influence work disability in women with FM [3,8,11-14].
These findings are supported by results of surveys con-
ducted in large populations [6,10]. However, it is difficult
to define to which extent symptom severity can be com-
patible with work. Assessments of physical, social and
psychological health components combining subjective
ratings with performance-based tests would advance our
understanding in this area.
Objective
The purpose of this study was to investigate which
aspects of health differ between working women (WW)
with FM and nonworking women (NWW) with FM. We
hypothesized that WW with FM would display better
health than NWW with FM in terms of subjective rat-




A cross -sectional study of work status and health in
women with FM.
Participants
Women with FM were recruited to an experimental
study [14] from three primary health-care centres in
West Sweden by systematic search of patient journals
and by consecutive recruitment. The inclusion criteria
were women who were 18–60 years of age and suffered
FM according to the American College of Rheumatology
(ACR) criteria for FM [1]. The search of patient journals
found 298 potentially eligible women who were con-
tacted by post (n = 55) or telephone (n = 243) for further
screening. Forty-eight women could not be contacted,
55 did not meet inclusion criteria at telephone screen-
ing, and 61 declined to participate in the study, while
134 agreed to participate in an examination. Twenty-
three of them did not meet inclusion criteria at exam-
ination, 17 were excluded due to; treatment in progress(n = 3), severe disorders (n = 9) or unemployment (n = 5)
and 18 declined to participate. At the same time,
93 women were consecutively recruited to the study.
Fifty-three of them fulfilled inclusion criteria and agreed
to participate in the study. A total of 129 women with
FM formed the study population. The study population
was divided into two groups according to work status;
WW (25-100%) and NWW (0%). The WW included 13
full-time workers (80-100%), 13 part-time workers work-
ing less than 50% (25-49%), 17 part-time workers work-
ing 50%, and 10 part-time workers working 50% or
more (50-75%). Thirty-seven part-time working women
received disability benefits while three did not. All
NWW received disability benefits.
Data collection
Clinical assessments of tender points by manual palpa-
tion [1] and muscle tenderness with the Somedic Alg-
ometer (Somedic Production AB, Sollentuna, Sweden)
[15] were conducted by trained examiners to verify diag-
nosis according to the American College of Rheumatol-
ogy criteria for FM [1]. Demographic data including
work status were gathered in a standardized interview.
The women completed a battery of questionnaires and
performed two tests of physical capacity described in de-
tail below. Aspects of health are presented according to
the International Classification of Function, Disability
and Health (ICF) [16].
Measures
Personal- and environmental factors
Information on age, employment, educational level, co-
habitation, ethnicity and brief medical history was
obtained in a standardized interview. Mean household
income per geographical area was based on zip codes
and obtained by Statistics Sweden1.
The Fibromyalgia Impact Questionnaire (FIQ) is dis-
ease specific and comprises ten subscales of disabilities
and symptoms ranging from 0 to 100. A higher score
indicates a lower health status [17]. The subscale FIQ
feel good is presented as a personal factor according to
the ICF [18].
Medical Outcome Study - Social Support Survey four-
item scale (MOS-SSS) is a short version of the 18-item
MOS-SSS consisting of a four-item social support scale
(1–5) covering four different categories of social support:
emotional, tangible, affectionate and positive social inter-
action. The total score ranges from four to 20. A higher
score indicates a higher degree of perceived social sup-
port [19].
Body function
The six-minute walk test (6MWT) is a performance-
based test that measures total walking distance during a
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a useful representation of physical capacity and endur-
ance in daily life [22].
Grippit (AB Detektor, Göteborg, Sweden) is an elec-
tronic instrument that measures hand grip force. The
mean force over a set period of time (ten seconds) was
recorded [20].
Pain localization, this is a self administered sheet that
records the number of pain localizations (0–18), based
on a drawing of the body with 18 predefined regions
[23].
The Fibromyalgia Impact Questionnaire (FIQ) is dis-
ease specific and comprises ten subscales of disabilities
and symptoms ranging from 0 to 100. A higher score
indicates a lower health status [17]. The subscales FIQ
pain, FIQ fatigue, FIQ morning tired, FIQ stiffness, FIQ
anxiety, and FIQ depression are presented as factors of
body function according to the ICF [18].
Hospital Anxiety and Depression Scale (HADS) con-
tains 14 statements, ranging from 0 to 3, in which a
higher score indicates a higher degree of distress. The
scores build two subscales: HADS-A for anxiety (0–21)
and HADS-D (0–21) for depression. The cut-off score of
eight is suggested to indicate possible anxiety and de-
pression [24]. This scale is categorized as a measure of
body function since 93% of its content concerns this ICF
domain [18].
Multidimensional Fatigue Inventory (MFI-20) contains
20 statements that build five subscales. Each subscale
ranges from four to 20 and a higher score indicates a
higher degree of fatigue [25,26]. This inventory is cate-
gorized as a measure of body function since 67% of its
content concerns this ICF domain [18].
Activity and participation
The Leisure Time Physical Activity Instrument (LTPAI) is
a questionnaire that assesses the amount of time spent
on physical activity during a typical week. The total
score is the sum of hours of activities [27].
The Fibromyalgia Impact Questionnaire (FIQ) is dis-
ease specific and comprises ten subscales of disabilities
and symptoms ranging from 0 to 100. A higher score
indicates a lower health status [17]. The subscale FIQ
physical function is presented as a factor of activity and
participation according to the ICF [18].
Health status – elements in overall health status
The Fibromyalgia Impact Questionnaire (FIQ) is disease
specific and comprises ten subscales of disabilities and
symptoms ranging from 0 to 100. The total score is
the mean of ten subscales. A higher score indicates a
lower health status [17]. Two subscales of the FIQ total
score were omitted here (Work missed and Job ability);
thus an eight-item total score of the FIQ was applied inthe study. FIQ subscales are presented according to
ICF [18].
Short-Form 36 (SF-36) is a generic questionnaire that
assesses health related quality of life, comprising eight
subscales ranging from 0 to 100. A higher score indi-
cates a better quality of life [28]. The subscales that build
two composite scores, the Physical Component Scale
(PCS) and the Mental Component Scale (MCS), were
used in this study and are presented as health status.
Statistical analysis
Descriptive data are presented as mean and standard de-
viation (SD), median and range or the number (N) and
percent. The Mann- Whitney U-test was used for ana-
lyses of between-group differences in continuous vari-
ables. The Mantel Haenzel test and Fisher’s exact test
were used for analyses of between-group differences in
ordinal categorical variables. P-values of ≤0.010 were
considered significant. To control possible Type I errors,
the upper limit of expected number of false significances
for the analyses was calculated by the following formula:
α/1– α × (number of tests – number of significant tests),
where α is the significance level. Variables displaying sta-
tistically significant differences in between-group ana-
lyses of WW and NWW were included in stepwise
multiple logistic regression analysis to evaluate explana-
tory factors for work. The order of inclusion was based
on the level of significance of each variable, where the
variable presenting the highest level of significance was
included first in the model. An odds-ratio (OR) with
95% CI is presented for descriptive purposes. The area
under the ROC curve (AUC statistics) was calculated for
a description of the goodness of explanatory variables.
Ethics
The study was approved by the ethics committee at the
Sahlgrenska Academy, University of Gothenburg. Writ-




The mean age was 45.7 years (SD 8.7). The mean dur-
ation of symptoms was 10.5 years (SD 7.1). The mean
number of tender points was 14.8 (SD 2.4) and the mean
pain threshold was 171 kPa/sec (SD 66). There were no
significant differences in pain threshold or the number
of tender points between WW and NWW.
Type I error
The between-group analyses comprised a total of 33
statistical analyses, with 11 significant values at signifi-
cance level 0.01, and the upper level of number of false
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nificances found might be false.
Personal- and environmental factors
Personal factors
No significant differences were found between WW and
NWW in personal factors.
Environmental factors
No significant differences were found between WW and
NWW in environmental factors (see Table 1).
Body function
Performance based tests of physical capacity
No significant differences were found between WW and
NWW.
Self rated body function
The number of pain localizations was fewer in WW than
in NWW (p = 0.009) and pain (FIQ pain) was milder in
WW than in NWW (p < 0.001). Stiffness (FIQ stiffness)
was milder in WW than in NWW (p = 0.009). Fatigue
was less severe in WW than in NWW (FIQ fatigue p =
0.006, MFI physical fatigue p = 0.001, MFI reduced activ-
ity p = 0.001 and MFI mental fatigue p = 0.006). WW
rated a lower level of depression (HADS-D) than NWW
(p = 0.007). Fifty-two percent of NWW and 29% of WW
scored above the cut-off score for possible depression.Table 1 Personal- and environmental factors in working wom
fibromyalgia
WW
Personal factors Mean (SD)
Age, years 45.4 (8.1)
Symptom duration, years 11.7 (5.8)
FIQ feel good, 0-100 69.0 (28.9)
N (%)
Living with an adult 45 (84.9)
Born outside of Sweden 8 (15.1)
Education:
≤ 9 years 11 (20.8)
10 – 12 years 29 (54.7)
>12 years 13 (24.5)
Pharmacological treatment:
Analgesic/NSAID, yes 31 (58.5)
Psychotropics, yes 22(41.5)
Environmental factors Mean (SD)
MOS-SSS, 4-20 15.4 (4.0)
Mean income in area of residence, 1000 Swedish kronor 214 (30.1)
P-values of ≤0.01 are considered significant and shown in bold type.
FIQ: Fibromyalgia Impact Questionnaire, MOS-SSS: Medical Outcome Study –Social
Missing values: FIQ feel good (n = 3), education (n = 1), mean income in the area ofThere was no significant difference in anxiety (HADS-A)
between WW and NWW. Fifty-eight percent of the
NWW and 47% of the WW scored above the cut-off
score for possible anxiety (8).
Activity and participation
No significant differences were found between WW and
NWW in leisure time physical activity (LTPAI) or activ-
ity limitations in daily life (FIQ physical function).
Health status
A better disease specific health status (FIQ total, eight-
item) was found in WW than in NWW (p = 0.001). This
was also true for physical health related quality of life
(SF-36 PCS) (p < 0.001) (see Table 2).
Stepwise multiple logistic regression analyses
Variables displaying a significant difference (p ≤ 0.010)
between WW with FM (n = 53) and NWW with FM
(n = 76) were included in stepwise multiple logistic
regression analysis. FIQ pain (n = 128) was the only sta-
tistically significant variable to independently explain
work (OR 0.95, CI 0.93- 0.98), p < 0.001, (AUC 0.75,
CI 0.66- 0.83).
Discussion
The main finding in this study was that working women
(WW) with FM displayed better ratings than nonworkingen (WW) and nonworking women (NWW) with
(N = 53) NWW (N = 76) p-value
Median (range) Mean (SD) Median (range)
47 (22–57) 46.0 (9.2) 47 (24–60) 0.567
10 (2–24) 9.7 (7.9) 8 (0.3-45) 0.021









Median (range) Mean (SD) Median (range)
16 (7–20) 14.5 (4.1) 15 (4–20) 0.267
214 (165–299) 201 (29.7) 205 (123–267) 0.042
Support Survey 4-item scale.
residence (n = 6).
Table 2 Body function, activity and health status in working women (WW) and nonworking women (NWW) with
fibromyalgia
WW (N = 53) NWW (N = 76) p-value
Body function, Mean (SD) Median (range) Mean (SD) Median (range)
Performance-based tests
6MWT, meters 520 (95.6) 524 (136–674) 500 (75.8) 512 (295–686) 0.087
Grippit right hand, Newton 160.3 (67.1) 155 (27–323) 146.1 (67.6) 160 (13–334) 0.284
Grippit left hand, Newton 158.6 (73.2) 155(17–349) 144.3 (65.4) 147 (19–319) 0.343
Body function, ratings
Pain localizations, number 12.5 (3.3) 13 (5–18) 14.0 (3.2) 14 (5–18) 0.009
FIQ pain, 0-100 62.5 (17.1) 63 (26–100) 77.0 (17.0) 80 (26–100) <0.001
FIQ fatigue, 0-100 75.4 (22.4) 83 (15–100) 84.8 (17.1) 90 (19–100) 0.006
FIQ morning tired, 0-100 76.9 (20.7) 81 (10–100) 83.6 (18.9) 89 (2–100) 0.017
FIQ stiffness, 0-100 64.0 (27.6) 75 (15–97) 75.6 (23.7) 82 (10–100) 0.009
FIQ anxiety, 0-100 42.1 (32.6) 38 (0–96) 52.5 (35.1) 54 (0–100) 0.060
FIQ depression, 0-100 39.2 (31.7) 32 (0–96) 48.5 (32.5) 51 (0–100) 0.116
HADS-A, 0-21 7.5 (4.8) 7 (1–19) 9.7 (5.2) 9 (1–20) 0.021
HADS-D, 0-21 6.2 (2.9) 6 (2–15) 8.0 (3.9) 8 (1–16) 0.007
MFI General Fatigue, 4-20 16.8 (3.0) 18 (9–20) 18.0 (2.4) 19 (12–20) 0.021
MFI Physical Fatigue, 4-20 16.2 (3.2) 17 (9–20) 18.0 (2.2) 19 (10–20) 0.001
MFI Reduced Activity, 4-20 14.5 (3.3) 14 (8–20) 16.5 (3.5) 17 (7–20) 0.001
MFI Reduced Motivation, 4-20 9.7 (3.1) 10 (5–16) 10.9 (4.3) 11 (4–19) 0.123
MFI Mental Fatigue, 4-20 13.5 (3.5) 14 (5–20) 15.1 (4.0) 16 (4–20) 0.006
Activity and participation
LTPAI, hours 4.5 (3.9) 3 (1–23) 5.4 (3.7) 4 (1–18) 0.088
FIQ physical function, 0-100 39.8 (20.5) 40 (3–90) 49.9 (23.1) 53 (0–100) 0.013
Health Status
FIQ total, 8-item, 0-100 58.7 (17.1) 63.5 (16–88) 69.3 (14.5) 71.3 (25–95) 0.001
SF-36 PCS, 0-100 32.6 (8.0) 33.3 (15–48) 27.0 (7.0) 27.6 (11–46) <0.001
SF-36 MCS, 0-100 41.6 (12.7) 43 (17–68) 36.8 (13.4) 37.5 (16–64) 0.043
P-values of ≤0.01 are considered significant and shown in bold type.
6MWT: six-minute walk test; FIQ: Fibromyalgia Impact Questionnaire; MFI: Multidimensional Fatigue Inventory; HADS-A and -D: Hospital Anxiety and Depression
Scale for - anxiety and - depression; LTPAI: Leisure Time Physical Activity Instrument; SF-36 PCS and MCS: Short Form −36, Physical Component Scale and Mental
Component Scale.
Missing values: Grippit (n = 1), FIQ Pain (n = 1), FIQ depression (n = 1), FIQ physical function (n = 2), LTPAI (n = 1), 8-item FIQ total (8) (n = 7), SF-36 (n = 3).
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ness, depression, disease specific health status and phys-
ical health related quality of life, which represent body
functions and overall health status.
Physical capacity did not differ significantly between
WW and NWW in terms of performance-based tests
(see Table 2) where both groups presented lower cap-
acity than the average population [20,21]. This supports
earlier studies showing impaired body function in
women with FM [4,29]. However, the physical work
demands might influence the work ability in persons
who have an impaired physical capacity. Earlier studies
have reported the importance of the work environment
in women with FM [8,11,13,30-32] and in other rheum-
atic diseases [33].The number of pain localizations was significantly
lower in WW than in NWW and global pain (FIQ pain)
was significantly milder in WW than in NWW (see
Table 2). The mean pain (FIQ pain) of WW was well
above 50 (0–100), which corresponds to the average pain
level in previous studies of FM [34]. Mean pain was
above 75 (0–100) in NWW, which corresponds to the
ratings of severely afflicted patients with FM [34]. FIQ
pain was found to be the only independent explanatory
factor for work in this study. Pain has previously been
found to be a critical factor for work in rheumatic dis-
eases [10,35]. Our results indicate that women with FM
having moderate pain generally could be expected to
work. Some women appear to be able to work despite
severe pain, which raises the question if there are
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work [32,36]. The influence of work related factors on
work ability in FM need to be further studied.
Global fatigue (FIQ fatigue) was found to be signifi-
cantly lower in WW than in NWW as well as physical
fatigue (MFI-20), reduced activity (MFI-20), and mental
fatigue (MFI-20) (see Table 2). Fatigue has previously
been found to be an important factor for work disability
in rheumatic diseases [35]. However, our results showed
severe global fatigue (FIQ fatigue) with mean ratings of
over 70 (0–100) [34] also in WW, indicating that fatigue
might not be a critical factor for work disability.
Depression was rated significantly lower in WW than
in NWW in the HADS, assessing depression. This sup-
ports the results of an earlier study on work disability in
FM reporting the negative impact of depression symp-
toms on work ability [37].
WW displayed a significantly better disease specific
health status (FIQ total, eight-item) than NWW (see
Table 2). This supports the results from an earlier study
on work disability in FM where the FIQ total score was
found to predict work disability [6]. Physical health-
related quality of life (SF-36 PCS) was significantly
higher in WW than in NWW (see Table 2), which is in
line with a previous study of FM [38]. However, the
quality of life of workers in our population, assessed by
SF-36, was very low as compared to a national sample
[39]. Impaired health status assessed by SF-36 has earlier
been associated with work disability in rheumatoid arth-
ritis (RA) [35], systemic lupus erythematosus (SLE) [40]
and musculoskeletal pain [41].
The theory of the healthy worker effect suggests that
healthier individuals are more likely to remain in the
workforce [42]. On one hand, this agrees well with the
results of the present study. On the other hand, work is
an important factor for health status in women in gen-
eral [43,44] and in women with FM [38]. Further studies
are needed to explore if working women with FM main-
tain their health status, or if it deteriorates over time.
The main strength of the present study is the integra-
tion of physical, social and psychological assessments in-
cluding subjective ratings as well as clinical assessments
and performance-based tests of physical capacity. About
40% of the patients in this study worked part-time or
full-time which is in line with international reports of
work ability in FM [8]. No significant differences were
found in age, symptom duration, cohabitation, ethnicity,
education, pharmacological treatment, mean income in
the area of residence and social support, i.e. personal
and environmental barriers or facilitators for health [16].
A limitation of this study is the cross sectional design
which does not allow analyses of cause and effect. Also,
the specific demands in work were not reported in the
study and need further investigation.Conclusions
Working women with FM reported better health than
nonworking women with FM in terms of pain, fatigue,
stiffness, depression, disease specific health status and
physical aspects of quality of life, which represent body
functions and overall health status. However, they were
equally impaired in tests of physical capacity. Moderate
pain levels were compatible with work, while severe pain
appeared to compromise work. Fatigue was better toler-
ated, as women scoring severe levels of fatigue worked.
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